Medios AG | Finanzwire

PRESS RELEASE

published on 05/12/2025 at 18:58, 8 months 17 days ago

Medios repositions itself for the next phase of its corporate development
Medios AG announces changes in Executive Board as part of corporate development transition. Founder and CEO to step down, COO to leave company. Focus on profitability and value creation. Professional search for CEO successor initiated

Profitability Executive Board Medios AG Corporate Development CEO Successor
PRESS RELEASE

published on 05/12/2025 at 18:56, 8 months 17 days ago

EQS-Adhoc: Changes to the Medios AG Executive Board; Matthias Gärtner will leave the company
Medios AG announces changes to its Executive Board with Matthias Gärtner, CEO, and Mi-Young Miehler, COO, leaving the company under mutual agreement for an organized transition

Executive Board Supervisory Board Medios AG Matthias Gärtner Mi-Young Miehler
BRIEF

published on 03/25/2025 at 07:55, 10 months 5 days ago

Medios AG Projects Continued Growth in 2025

Revenue Forecast Medios AG EBITDA Increase Specialty Pharma 2025 Growth
PRESS RELEASE

published on 03/25/2025 at 07:50, 10 months 5 days ago

Medios expects further growth in revenue and earnings after record year 2024
Medios expects further growth in revenue and earnings after a record year in 2024. Consolidated revenue up 5.5% to €1.9 billion. EBITDA pre1 margin reaches 4.2%. Positive outlook for 2025 with revenue expected to reach €2.0 billion

Revenue Growth Earnings Forecast Record Year Medios 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 10 months 26 days ago

Medios AG Reports Strong Earnings Growth in 2024, Eyes Further Gains in 2025

Pharmaceutical Industry Medios AG Financial Growth 2024 Results 2025 Outlook
PRESS RELEASE

published on 03/04/2025 at 08:50, 10 months 26 days ago

Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025
Medios AG reports significant increase in earnings and margins for 2024, positive outlook for 2025. Preliminary figures show revenue reaching €1.9 billion and EBITDA pre1 around €79 million

Revenue Outlook Earnings Medios AG Margins
BRIEF

published on 12/12/2024 at 13:32, 1 year 1 month ago

Medios AG Adjusts Full-Year Financial Forecast

Revenue Increase EBITDA Margin Financial Forecast Medios AG Specialty Pharma
PRESS RELEASE

published on 12/12/2024 at 13:27, 1 year 1 month ago

EQS-Adhoc: Medios AG: Specification of the full-year forecast
Medios AG specifies full-year forecast: revenues expected to be c. €1.85 billion & EBITDA pre1 of c. €80 million, with an EBITDA pre1 margin around 4.3%

Revenues Medios AG Margin Full-year Forecast EBITDA Pre1
BRIEF

published on 11/12/2024 at 08:46, 1 year 2 months ago

Medios AG Achieves Record Third Quarter in 2024

Medios AG Earnings Growth Financial Outlook Q3 2024 Specialty Pharma
PRESS RELEASE

published on 11/12/2024 at 08:41, 1 year 2 months ago

Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins
Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins. EBITDA pre1 reaches €24.6 million (+42.9%) and revenue in the nine-month period up 4.2%

Revenue Growth Medios AG Earnings Increase EBITDA Pre1 Record Quarter

Published on 01/30/2026 at 14:00, 2 hours 15 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 40 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 15 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 14 hours ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 15 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

Published on 01/30/2026 at 16:00, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 15:59, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/30/2026 at 15:58, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc
Published on 01/30/2026 at 15:57, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/30/2026 at 15:56, 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

View all EQS

Published on 01/30/2026 at 08:00, 8 hours 15 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 22 hours 15 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 22 hours 35 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News